Photo taken from American Association for Cancer Research/LinkedIn
Apr 28, 2024, 14:39
Harpreet Singh: Join us for what promises to be an exciting and informative workshop on the approach to resectable, early stage tumors
Harpreet Singh, Division Direction at FDA Oncology shared a post by American Association for Cancer Research on LinkedIn, adding:
“Join us for what promises to be an exciting and informative workshop on the approach to resectable, early stage tumors.”
Quoting American Association for Cancer Research’s post:
“How Much is Enough? Trial designs for treatment regimens with multiple phases, AACR Past President Elizabeth M. Jaffee joins FDA’s Harpreet Singh to chair this AACR-FDA workshop. Join us May 9 in Bethesda, MD, or on livestream. Learn more.”
Source: Harpreet Singh/LinkedIn and American Association for Cancer Research/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19